Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liquidia Technologies Inc

15.99
+0.24001.52%
Volume:884.08K
Turnover:13.98M
Market Cap:1.37B
PE:-9.36
High:16.17
Open:15.87
Low:15.44
Close:15.75
Loading ...

Liquidia Faces Patent Litigation Filed by United Therapeutics

MT Newswires Live
·
12 May

Stock Track | Liquidia Technologies Surges 5.18% Pre-Market as HC Wainwright Maintains $29 Price Target

Stock Track
·
12 May

Liquidia Price Target Maintained With a $29.00/Share by HC Wainwright & Co.

Dow Jones
·
12 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Vir Biotechnology (VIR) and Liquidia Technologies (LQDA)

TIPRANKS
·
09 May

Liquidia Shares Fall After Q1 Net Loss Widens, Revenue Trails Analyst Estimates

MT Newswires Live
·
08 May

Liquidia Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Earnings Flash (LQDA) Liquidia Posts Q1 Net Loss $0.45 a Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
08 May

Liquidia Q1 EPS $(0.45) Misses $(0.41) Estimate, Sales $3.12M Miss $3.27M Estimate

Benzinga
·
08 May

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
08 May

Liquidia Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
05 May

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

Zacks
·
05 May

Court dismisses United Therapeutics’ dispute against Liquidia

TIPRANKS
·
03 May

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

THOMSON REUTERS
·
03 May

Liquidia Corp - FDA Sets Pdufa Goal Date for Yutrepia Nda on May 24, 2025

THOMSON REUTERS
·
03 May

Liquidia Corp - FDA Can Grant Final Approval of Yutrepia After Blocking Regulatory Exclusivity Expires on May 23, 2025

THOMSON REUTERS
·
03 May

Liquidia rallies after judge rules against bid to delay Yutrepia

TIPRANKS
·
03 May

Liquidia up 13% to $15.85 in afternoon trading

TIPRANKS
·
03 May

Press Release: Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Dow Jones
·
01 May

Urogen Pharma (URGN) Moves 14.1% Higher: Will This Strength Last?

Zacks
·
29 Apr

Scotiabank Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

TIPRANKS
·
23 Apr